PLCD1 is a functional tumor suppressor inducing G2/M arrest and frequently methylated in breast cancer

Cancer Biology and Therapy

Volumn 10, Issue 5, 2010, Pages 520-527

  Xiang, Tingxiu ^a   Li, Li ^b   Fan, Yichao ^b   Jiang, Yanyan ^a   Ying, Ying ^b   Putti, Thomas C ^c   Tao, Qian ^a,b   Ren, Guosheng ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Breast cancer; Methylation; PLCD1; Tumor suppressor gene

Indexed keywords

PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE PHOSPHODIESTERASE;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER DIAGNOSIS; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL MIGRATION; COLONY FORMATION; DEMETHYLATION; DOWN REGULATION; EPIGENETICS; GENE LOCUS; GENE SEQUENCE; GENE SILENCING; HUMAN; HUMAN TISSUE; METHYLATION; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION;

BREAST NEOPLASMS; CELL DIVISION; CELL LINE, TUMOR; CHROMOSOMES, HUMAN, PAIR 3; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; G2 PHASE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; PHOSPHOLIPASE C DELTA; POLYMERASE CHAIN REACTION; PROGNOSIS; PROMOTER REGIONS, GENETIC; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS;

EID: 77957143981     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.10.5.12726     Document Type: Article

References (33)

1. McCracken M, Olsen M, Chen MS Jr, Jemal A, Thun M, Cokkinides V, et al. Cancer incidence, mortality and associated risk factors among Asian Americans of Chinese, Filipino, Vietnamese, Korean and Japanese ethnicities. CA Cancer J Clin 2007; 57:190-205. (Pubitemid 47312080)
2. Wood LD, Parsons DW, Jones S, Lin J, Sjoblom T, Leary RJ, et al. The genomic landscapes of human breast and colorectal cancers. Science 2007; 318:1108-13.
3. Jones PA, Baylin SB. The epigenomics of cancer. Cell 2007; 128:683-92.
4. Corn PG. Methylation marks the path for biomarker development in breast cancer research. Cancer Biol Ther 2009; 8.
5. Ahmed S, Thomas G, Ghoussaini M, Healey CS, Humphreys MK, Platte R, et al. Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat Genet 2009; 41:585-90.
6. Yang Q, Yoshimura G, Mori I, Sakurai T, Kakudo K. Chromosome 3p and breast cancer. J Hum Genet 2002; 47:453-9.
7. Qiu GH, Tan LK, Loh KS, Lim CY, Srivastava G, Tsai ST, et al. The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma. Oncogene 2004; 23:4793-806. (Pubitemid 38859468)
8. 1 arrest in cell cycle. J Hepatol 2008; 48:433-41.
9. Hu XT, Zhang FB, Fan YC, Shu XS, Wong AH, Zhou W, et al. Phospholipase Cdelta1 is a novel 3p22.3 tumor suppressor involved in cytoskeleton organization, with its epigenetic silencing correlated with high-stage gastric cancer. Oncogene 2009; 28:2466-75.
10. Agathanggelou A, Dallol A, Zochbauer-Muller S, Morrissey C, Honorio S, et al. Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers. Oncogene 2003; 22:1580-8.
11. Dulaimi E, Hillinck J, Ibanez de Caceres I, Al-Saleem T, Cairns P. Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients. Clin Cancer Res 2004; 10:6189-93.
12. Fackler MJ, McVeigh M, Mehrotra J, Blum MA, Lange J, Lapides A, et al. Quantitative multiplex methylation-specific PCR assay for the detection of promoter hypermethylation in multiple genes in breast cancer. Cancer Res 2004; 64:4442-52.
13. Janetopoulos C, Devreotes P. Phosphoinositide signaling plays a key role in cytokinesis. J Cell Biol 2006; 174:485-90. (Pubitemid 44231860)
14. Drin G, Scarlata S. Stimulation of phospholipase Cbeta by membrane interactions, interdomain movement and G protein binding - how many ways can you activate an enzyme? Cell Signal 2007; 19:1383-92.
15. Suh PG, Park JI, Manzoli L, Cocco L, Peak JC, Katan M, et al. Multiple roles of phosphoinositide-specific phospholipase C isozymes. BMB Rep 2008; 41:415-34.
16. Rebecchi MJ, Raghubir A, Scarlata S, Hartenstine MJ, Brown T, Stallings JD. Expression and function of phospholipase C in breast carcinoma. Adv Enzyme Regul 2009; 49:59-73.
17. Essen LO, Perisic O, Cheung R, Katan M, Williams RL. Crystal structure of a mammalian phosphoinositide-specific phospholipase C delta. Nature 1996; 380:595-602. (Pubitemid 26119011)
18. Fu L, Qin YR, Xie D, Hu L, Kwong DL, Srivastava G, et al. Characterization of a novel tumor-suppressor gene PLC delta1 at 3p22 in esophageal squamous cell carcinoma. Cancer Res 2007; 67:10720-6.
19. Ying J, Srivastava G, Hsieh WS, Gao Z, Murray P, Liao SK, et al. The stress-responsive gene GADD45G is a functional tumor suppressor, with its response to environmental stresses frequently disrupted epigenetically in multiple tumors. Clin Cancer Res 2005; 11:6442-9.
20. Wang Y, Li J, Cui Y, Li T, Ng KM, Geng H, et al. located at the critical tumor suppressor locus 16q22.1, is silenced by CpG methylation in carcinomas and inhibits tumor cell growth through inducing apoptosis. Cancer Res 2009; 69:5194-201.
21. Cui Y, Ying Y, van Hasselt A, Ng KM, Yu J, Zhang Q, et al. OPCML is a broad tumor suppressor for multiple carcinomas and lymphomas with frequently epigenetic inactivation. PLoS One 2008; 3:2990.
22. Ying J, Li H, Chen YW, Srivastava G, Gao Z, Tao Q. WNT5A is epigenetically silenced in hematologic malignancies and inhibits leukemia cell growth as a tumor suppressor. Blood 2007; 110:4130-2. (Pubitemid 350248475)
23. Jin H, Wang X, Ying J, Wong AH, Cui Y, Srivastava G, et al. Epigenetic silencing of a Ca(2+)-regulated Ras GTPase-activating protein RASAL defines a new mechanism of Ras activation in human cancers. Proc Natl Acad Sci USA 2007; 104:12353-8.
24. Tao Q, Huang H, Geiman TM, Lim CY, Fu L, Qiu GH, Robertson KD. Defective de novo methylation of viral and cellular DNA sequences in ICF syndrome cells. Hum Mol Genet 2002; 11:2091-102. (Pubitemid 34993997)
25. Tao Q, Swinnen LJ, Yang J, Srivastava G, Robertson KD, Ambinder RF. Methylation status of the Epstein-Barr virus major latent promoter C in iatrogenic B cell lymphoproliferative disease. Application of PCR-based analysis. Am J Pathol 1999; 155:619-25.
26. Hesson LB, Cooper WN, Latif F. Evaluation of the 3p21.3 tumour-suppressor gene cluster. Oncogene 2007; 26:7283-301.
27. Zabarovsky ER, Lerman MI, Minna JD. Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers. Oncogene 2002; 21:6915-35.
28. Smiraglia DJ, Rush LJ, Fruhwald MC, Dai Z, Held WA, Costello JF, et al. Excessive CpG island hypermethylation in cancer cell lines versus primary human malignancies. Hum Mol Genet 2001; 10:1413-9.
29. Paz MF, Wei S, Cigudosa JC, Rodriguez-Perales S, Peinado MA, Huang TH, Esteller M. Genetic unmasking of epigenetically silenced tumor suppressor genes in colon cancer cells deficient in DNA methyltransferases. Hum Mol Genet 2003; 12:2209-19. (Pubitemid 37107311)
30. Sidhu RS, Clough RR, Bhullar RP. Regulation of phospholipase C-delta1 through direct interactions with the small GTPase Ral and calmodulin. J Biol Chem 2005; 280:21933-41.
31. Qin YR, Fu L, Sham PC, Kwong DL, Zhu CL, Chu KK, et al. Single-nucleotide polymorphism-mass array reveals commonly deleted regions at 3p22 and 3p14.2 associate with poor clinical outcome in esophageal squamous cell carcinoma. Int J Cancer 2008; 123:826-30. (Pubitemid 352032408)
32. Stallings JD, Tall EG, Pentyala S, Rebecchi MJ. Nuclear translocation of phospholipase C-delta1 is linked to the cell cycle and nuclear phosphatidylinositol 4,5-bisphosphate. J Biol Chem 2005; 280:22060-9. (Pubitemid 40827861)
33. 1- to S-phase by control of cyclin E-CDK2 activity. Biochem J 2008; 415:439-48.